Petco Health and Wellness Co. (WOOF)
(Real Time Quote from BATS)
$4.62 USD
-0.31 (-6.29%)
Updated Sep 20, 2024 12:28 PM ET
2-Buy of 5 2
A Value B Growth D Momentum A VGM
Price, Consensus and EPS Surprise
WOOF 4.62 -0.31(-6.29%)
Will WOOF be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for WOOF based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for WOOF
Should Value Investors Buy Petco Health and Wellness Co. (WOOF) Stock?
Petco (WOOF) Upgraded to Buy: Here's Why
WOOF: What are Zacks experts saying now?
Zacks Private Portfolio Services
Are Retail-Wholesale Stocks Lagging Texas Roadhouse (TXRH) This Year?
Chewy Stock Up 23% in a Month: Is it Time to Buy, Hold or Cash Out?
Petco Health & Wellness (WOOF) Reports Q2 Loss, Misses Revenue Estimates
Other News for WOOF
Winmark Corporation: Still Overvalued, And Still Expected To Decline In Price
Unusually active option classes on open September 12th
Petco price target raised by 50c at Citi, here's why
Petco's Q2 Results Show Promise Amid Strategic Shift
Petco (WOOF) Shares Surge on Positive Q2 Results